FLAW
发表于 2025-3-21 16:22:32
书目名称Cutaneous Biometrics影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0241657<br><br> <br><br>书目名称Cutaneous Biometrics读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0241657<br><br> <br><br>
GUEER
发表于 2025-3-21 20:43:18
http://reply.papertrans.cn/25/2417/241657/241657_2.png
defibrillator
发表于 2025-3-22 01:25:37
http://reply.papertrans.cn/25/2417/241657/241657_3.png
xanthelasma
发表于 2025-3-22 05:48:22
New Unionism and New Politics, 1880–1900nsiveness. Here, PDAI, ABSIS, and PVAS are presented and compared based on their measurement properties including reliability, feasibility, and correlation with anti-desmoglein using one large prospective study (n = 100) comparing all three measures. Also, a review of additional properties including
flourish
发表于 2025-3-22 10:04:41
The Formation of a Pressure Group, 1860–80erity assessment is most commonly measured specifically through changes in facial erythema, followed by papules and pustular count and then telangiectasia. Visual inspection by a clinician is the most common modality of assessment of erythema, with a four-point scale as the most frequent methodology
档案
发表于 2025-3-22 16:43:09
http://reply.papertrans.cn/25/2417/241657/241657_6.png
档案
发表于 2025-3-22 20:58:37
erstanding of the importance of creating meaningful dermatological patient outcome measurements and the use of the physician global assessment in a clinical setting to measure and track patient outcomes.Details978-3-319-56591-0
semiskilled
发表于 2025-3-22 21:42:27
Atopic Dermatitis Outcome Measures,ndex (DLQI) being two of the more preferred measures for eczema clinical trials, although the better of the two is yet to be decided by consensus. HOME is also making progress toward defining the core outcome measure for the long-term control domain, with future consensus meetings planned.
流浪者
发表于 2025-3-23 03:18:48
http://reply.papertrans.cn/25/2417/241657/241657_9.png
hypnogram
发表于 2025-3-23 06:00:46
http://reply.papertrans.cn/25/2417/241657/241657_10.png